Literature DB >> 19948220

Sulforaphane protects ischemic injury of hearts through antioxidant pathway and mitochondrial K(ATP) channels.

Cheng Shi Piao1, Shan Gao, Geum-Hwa Lee, Do Sung Kim, Byung-Hyun Park, Soo Wan Chae, Han-Jung Chae, Suhn Hee Kim.   

Abstract

Reactive oxygen species are important mediators that exert a toxic effect during ischemia-reperfusion (I/R) injury of various organs. Sulforaphane is known to be an indirect antioxidant that acts by inducing Nrf2-dependent phase 2 enzymes. In this study, we investigated whether sulforaphane protects heart against I/R injury. Sprague-Dawley rats received sulforaphane (500microg/kg/day) or vehicle intraperitoneally for 3 days and global ischemia was performed using isolated perfused Langendorff hearts. Hearts were perfused with Krebs-bicarbonate buffer for 20min pre-ischemic period followed by a 20min global ischemia and 50min reperfusion. Treatment with sulforaphane inhibited an increase in the post-ischemic left ventricular end-diastolic pressure (LVEDP) and improved the post-ischemic left ventricular developed pressure (LVDP), +/-dP/dt, and coronary flow as compared with the untreated control hearts. Pretreatment with 5-hydroxydecanoic acid (5-HD), a mitochondrial K(ATP) channel blocker, for 10min before ischemia attenuated the improvement of LVEDP, LVDP, +/-dP/dt, and coronary flow induced by sulforaphane. Sulforaphane markedly decreased the infarcted size and attenuated the increased lactate dehydrogenase level in effluent during reperfusion. Pretreatment with 5-HD also blocked these protective effects of sulforaphane. Post-ischemia increased the concentration of atrial natriuretic peptide in coronary effluent, which attenuated by sulforaphane treatment. Decreases on Mn-superoxide dismutase (SOD), catalase, and heme oxygenase-1 levels by I/R were increased by sulforaphane treatment and pretreatment of 5-HD blocked the sulforaphane effects. Increases in Bax and caspase-3 levels, and decrease in Bcl-2 level by I/R were attenuated by sulforaphane treatment. These results suggest that the protective effects of sulforaphane against I/R injury may be partly mediated through mitochondrial K(ATP) channels and antioxidant pathway. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19948220     DOI: 10.1016/j.phrs.2009.11.009

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  40 in total

1.  Nrf2, a guardian of healthspan and gatekeeper of species longevity.

Authors:  Kaitlyn N Lewis; James Mele; John D Hayes; Rochelle Buffenstein
Journal:  Integr Comp Biol       Date:  2010-05-06       Impact factor: 3.326

2.  Bioavailability and inter-conversion of sulforaphane and erucin in human subjects consuming broccoli sprouts or broccoli supplement in a cross-over study design.

Authors:  John D Clarke; Anna Hsu; Ken Riedl; Deborah Bella; Steven J Schwartz; Jan F Stevens; Emily Ho
Journal:  Pharmacol Res       Date:  2011-07-26       Impact factor: 7.658

Review 3.  Nrf2 at the heart of oxidative stress and cardiac protection.

Authors:  Qin M Chen; Anthony J Maltagliati
Journal:  Physiol Genomics       Date:  2017-11-29       Impact factor: 3.107

Review 4.  Plant science and human nutrition: challenges in assessing health-promoting properties of phytochemicals.

Authors:  Maria H Traka; Richard F Mithen
Journal:  Plant Cell       Date:  2011-07-29       Impact factor: 11.277

5.  The Protective Effect of Epigallocatechin-3 Gallate on Ischemia/Reperfusion Injury in Isolated Rat Hearts: An ex vivo Approach.

Authors:  Cheng Shi Piao; Do-Sung Kim; Ki-Chan Ha; Hyung-Ryong Kim; Han-Jung Chae; Soo-Wan Chae
Journal:  Korean J Physiol Pharmacol       Date:  2011-10-31       Impact factor: 2.016

6.  Challenging oneself intermittently to improve health.

Authors:  Mark P Mattson
Journal:  Dose Response       Date:  2014-10-20       Impact factor: 2.658

7.  Sulforaphane protects the heart from doxorubicin-induced toxicity.

Authors:  Preeti Singh; Rajendra Sharma; Kevin McElhanon; Charles D Allen; Judit K Megyesi; Helen Beneš; Sharda P Singh
Journal:  Free Radic Biol Med       Date:  2015-05-27       Impact factor: 7.376

Review 8.  Nrf2-a Promising Therapeutic Target for Defensing Against Oxidative Stress in Stroke.

Authors:  Rongrong Zhang; Mengxue Xu; Yu Wang; Fei Xie; Gang Zhang; Xinyue Qin
Journal:  Mol Neurobiol       Date:  2016-09-30       Impact factor: 5.590

9.  Nrf2 enhances myocardial clearance of toxic ubiquitinated proteins.

Authors:  Wenjuan Wang; Siying Li; Hui Wang; Bin Li; Lei Shao; Yimu Lai; Gary Horvath; Qian Wang; Masayuki Yamamoto; Joseph S Janicki; Xing Li Wang; Dongqi Tang; Taixing Cui
Journal:  J Mol Cell Cardiol       Date:  2014-04-18       Impact factor: 5.000

10.  Sulforaphane prevents rat cardiomyocytes from hypoxia/reoxygenation injury in vitro via activating SIRT1 and subsequently inhibiting ER stress.

Authors:  Yun-peng Li; Shu-lin Wang; Bei Liu; Lu Tang; Rong-ren Kuang; Xian-bao Wang; Cong Zhao; Xu-dong Song; Xue-ming Cao; Xiang Wu; Ping-zhen Yang; Li-zi Wang; Ai-hua Chen
Journal:  Acta Pharmacol Sin       Date:  2016-01-18       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.